Warning letterFDA · Nov 14, 2022
iwi MARCS-CMS 636312, November 14, 2022
Named company: iwi
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, iwi Cholesterol fails to bear adequate…
Lot information: not specified in this record.